-
Add to Cart The item has been addedD659329-5mgDabcyl-KTSAVLQSGFRKME-Edans TFA is a fluorogenic peptide. Dabcyl-KTSAVLQSGFRKME-Edans TFA is used as the substrate to measure the enzymatic activities of protease forms. Dabcyl-KTSAVLQSGFRKME-Edans TFA has the potential for study 2019-nCoV -
Add to Cart The item has been addedD406460-2KUProduct DescriptionIn the process of large-scale mRNA production, the transcription template needs to be removed after transcription. DNase I can randomly decompose single-stranded or double-stranded DNA to the same degree to generate -
Add to Cart The item has been addedD406460-400UProduct DescriptionIn the process of large-scale mRNA production, the transcription template needs to be removed after transcription. DNase I can randomly decompose single-stranded or double-stranded DNA to the same degree to generate -
Add to Cart The item has been addedE406458-100UProduct DescriptionThe introduction of Poly A tail at the 3'end of mRNA by tailing enzyme can increase the stability of mRNA and increase the efficiency of mRNA translation. The advantage of using the tailing enzyme to introduce the Poly A tail is -
Add to Cart The item has been addedG650399-10mgGS-621763, an orally bioavailable proagent of GS-441524, shows antiviral activity against SARS-CoV-2 pathogenesis in mice.Form:Solid -
Add to Cart The item has been addedG650399-1mgGS-621763, an orally bioavailable proagent of GS-441524, shows antiviral activity against SARS-CoV-2 pathogenesis in mice.Form:Solid -
Add to Cart The item has been addedG650399-25mgGS-621763, an orally bioavailable proagent of GS-441524, shows antiviral activity against SARS-CoV-2 pathogenesis in mice.Form:Solid -
Add to Cart The item has been addedG650399-5mgGS-621763, an orally bioavailable proagent of GS-441524, shows antiviral activity against SARS-CoV-2 pathogenesis in mice.Form:Solid -
Add to Cart The item has been addedH658721-100mgHCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC 50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively.Appearance:SolidIC50& Target:IC50: 0.65 μM (HCoV-229E)In Vitro:HCoV-229E-IN-1 (compound 5h) (0.01-100 μM) fully -
Add to Cart The item has been addedH658721-10mgHCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC 50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively.Appearance:SolidIC50& Target:IC50: 0.65 μM (HCoV-229E)In Vitro:HCoV-229E-IN-1 (compound 5h) (0.01-100 μM) fully -
Add to Cart The item has been addedH658721-25mgHCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC 50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively.Appearance:SolidIC50& Target:IC50: 0.65 μM (HCoV-229E)In Vitro:HCoV-229E-IN-1 (compound 5h) (0.01-100 μM) fully -
Add to Cart The item has been addedH658721-50mgHCoV-229E-IN-1 is a potent inhibitor of HCoV-229E replication, with an EC 50 of 0.65 μM and 0.6 μM in MTS and CPE cells, respectively.Appearance:SolidIC50& Target:IC50: 0.65 μM (HCoV-229E)In Vitro:HCoV-229E-IN-1 (compound 5h) (0.01-100 μM) fully
